A monoclonal antibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to a …

Dec 10, 2025 · Monoclonal antibodies can treat autoimmune conditions, cancers and other diseases by working with your immune system.

An open access journal publishing antibody research on topics including targets relevant to cancer and immune-mediated disorders, and antibody therapeutics.

Jun 3, 2025 · The mAb (ibritumomab) delivers a radioactive substance (Yttrium-90) directly to cancer cells. Another example is Kadcyla, an mAb that is attached to a chemotherapy drug.

Bevacizumab (Avastin) is an mAb that targets a protein called VEGF that affects tumor blood vessel growth. It can cause side effects such as high blood pressure, bleeding, poor wound healing, blood …

Apr 19, 2023 · A monoclonal antibody (mAb) is a type of immune protein produced in a lab that binds to a specific protein on a cell called an antigen. As with naturally occurring antibodies, monoclonal …

Monoclonal antibodies (mAb) are defined as the antibodies derived from a single clone of plasma cell, all having the same antigen specificity, i.e. produced against a single epitope of an antigen.

A therapeutic monoclonal antibody (mAb) is a homogenous collection of antibodies used to treat an illness. They are selected for their affinity to a target antigen.

Monoclonal antibodies (mAb) are proteins that are produced in a laboratory or plant and can act as antibodies which are produced by the human body. They are “monoclonal” because they are clones, or …

Aug 18, 2025 · According to the World Health Organization (WHO), which is responsible for therapeutic mAb nomenclature, over 800 mAb names have been provided [1]. (See 'Naming conventions' below.)